Safety and Effectiveness of Inebilizumab in Patients with Neuromyelitis Optica Spectrum Disorder: Interim Analysis of a Post-marketing Surveillance in Japan

Kazuo Fujihara, Shinya Hirota, Muneyoshi Kudo, Hideaki Hida, Satoshi Yuki, Takashi Narisawa, Kyoko Kato

Open source

DOI: 10.1007/s40120-026-01008-9
Published: 2026-08-28
Container: Neurology and Therapy
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s40120-026-01008-9,
  title = {Safety and Effectiveness of Inebilizumab in Patients with Neuromyelitis Optica Spectrum Disorder: Interim Analysis of a Post-marketing Surveillance in Japan},
  author = {Kazuo Fujihara and Shinya Hirota and Muneyoshi Kudo and Hideaki Hida and Satoshi Yuki and Takashi Narisawa and Kyoko Kato},
  year = {2026},
  journal = {Neurology and Therapy},
  doi = {10.1007/s40120-026-01008-9},
  url = {https://doi.org/10.1007/s40120-026-01008-9}
}

RIS

TY  - JOUR
TI  - Safety and Effectiveness of Inebilizumab in Patients with Neuromyelitis Optica Spectrum Disorder: Interim Analysis of a Post-marketing Surveillance in Japan
AU  - Kazuo Fujihara
AU  - Shinya Hirota
AU  - Muneyoshi Kudo
AU  - Hideaki Hida
AU  - Satoshi Yuki
AU  - Takashi Narisawa
AU  - Kyoko Kato
PY  - 2026
JO  - Neurology and Therapy
DO  - 10.1007/s40120-026-01008-9
UR  - https://doi.org/10.1007/s40120-026-01008-9
ER  -

APA

Fujihara, K., Hirota, S., Kudo, M., Hida, H., Yuki, S., Narisawa, T., & Kato, K. (2026). Safety and Effectiveness of Inebilizumab in Patients with Neuromyelitis Optica Spectrum Disorder: Interim Analysis of a Post-marketing Surveillance in Japan. Neurology and Therapy. https://doi.org/10.1007/s40120-026-01008-9

Source records

crossref · retrieved 2026-09-25T01:29:25.811Z